[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:healthy-participants":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":167,"states":168},"Healthy Participants",26,21,[8,16,22,28,34,40,47,53,59,65,71,77,83,89,95,100,106,112,118,124,130,136,144,150,157,162],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07511205","A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and\u002For Obesity.",[12],"Phase 1","RECRUITING","2026-08-26T02:16:39.977107Z","2026-05-05T02:43:29.048433Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07513571","A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults",[12],"2026-08-03T02:27:16.454962Z","2026-05-05T02:43:28.535819Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07290283","A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants",[12],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:28.469910Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07487740","A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants",[12],"2026-08-03T02:29:26.433866Z","2026-05-05T02:43:27.512332Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT06854042","A Study of Oral E1018 in Healthy Adult Participants",[12],"2026-08-03T02:20:20.314190Z","2026-05-05T02:43:27.132269Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":45,"content_modified":46},"NCT07344948","Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia",[44],"Early Phase 1","2026-08-26T02:16:38.053590Z","2026-05-05T02:43:26.673942Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06980428","A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia",[12],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:29.671201Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07390474","Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV",[12],"2026-08-26T02:17:18.747857Z","2026-05-05T02:43:28.178987Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT07723833","A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants",[12],"2026-08-26T02:17:33.002248Z","2026-07-24T01:27:14.923443Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT07390136","Sparking Potential, Revealing Infant Neurocognitive Traits",[],"2026-08-26T02:18:13.438956Z","2026-05-13T02:55:06.698784Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT07413900","Biomarkers Study in Infants With Prior Neonatal Brain Injury",[],"2026-08-26T02:18:17.007929Z","2026-05-13T02:55:06.701319Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT07170202","The Increasing Mindfulness Engagement Project",[],"2026-08-26T02:15:04.877798Z","2026-07-19T19:36:05.064166Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT07498270","Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep",[],"2026-08-26T02:18:15.214990Z","2026-07-05T05:32:16.682520Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT07545226","Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.",[12],"2026-08-03T01:02:00.666143Z","2026-07-05T03:45:20.252886Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":45,"content_modified":99},"NCT07650058","Postprandial Effects of Fresh Mango as a Table Sugar Replacement in High-Sugar Breakfasts.",[],"2026-06-17T02:29:30.058502Z",{"nct_id":101,"title":102,"phases":103,"status":13,"updated_at":104,"content_modified":105},"NCT07305259","Researching Economical Adjuvants to Cancer Therapy",[44],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:28.876998Z",{"nct_id":107,"title":108,"phases":109,"status":13,"updated_at":110,"content_modified":111},"NCT07412288","First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants",[12],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:28.549410Z",{"nct_id":113,"title":114,"phases":115,"status":13,"updated_at":116,"content_modified":117},"NCT06961747","A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women",[12],"2026-08-26T02:15:11.740957Z","2026-05-05T02:43:27.795096Z",{"nct_id":119,"title":120,"phases":121,"status":13,"updated_at":122,"content_modified":123},"NCT07220655","Cognition and Ultrasound",[],"2026-08-26T02:17:36.611194Z","2026-05-05T02:43:27.404604Z",{"nct_id":125,"title":126,"phases":127,"status":13,"updated_at":128,"content_modified":129},"NCT07371598","Royal Ancient Oats™ Study",[],"2026-08-26T02:16:06.684983Z","2026-05-05T02:43:26.710430Z",{"nct_id":131,"title":132,"phases":133,"status":13,"updated_at":134,"content_modified":135},"NCT07459803","Investigating Individual Differences in Speech Motor Skills in Neurotypical Speakers and Persons With Disordered Speech",[],"2026-08-26T02:16:46.951087Z","2026-05-05T02:43:27.601684Z",{"nct_id":137,"title":138,"phases":139,"status":141,"updated_at":142,"content_modified":143},"NCT07593222","Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder",[140],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-26T02:16:01.079019Z","2026-05-29T15:36:40.203036Z",{"nct_id":145,"title":146,"phases":147,"status":141,"updated_at":148,"content_modified":149},"NCT07602335","Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants",[44],"2026-08-26T02:19:26.493949Z","2026-07-05T05:32:16.641377Z",{"nct_id":151,"title":152,"phases":153,"status":154,"updated_at":155,"content_modified":156},"NCT07534592","A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T02:29:52.097456Z","2026-05-05T02:43:29.059401Z",{"nct_id":158,"title":159,"phases":160,"status":154,"updated_at":38,"content_modified":161},"NCT07361354","A Phase 1 Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)",[12],"2026-05-05T02:43:26.903281Z",{"nct_id":163,"title":164,"phases":165,"status":154,"updated_at":32,"content_modified":166},"NCT07422285","Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose",[12],"2026-05-05T02:43:28.673719Z",[],[169,173,177,181,184,188],{"state":170,"count":171,"slug":172},"California",9,"california",{"state":174,"count":175,"slug":176},"Florida",6,"florida",{"state":178,"count":179,"slug":180},"Maryland",5,"maryland",{"state":182,"count":179,"slug":183},"Texas","texas",{"state":185,"count":186,"slug":187},"Wisconsin",4,"wisconsin",{"state":189,"count":190,"slug":191},"Massachusetts",3,"massachusetts"]